This federal contract award is for the delivery of the radiopharmaceutical products Lutetium Lu 177 LUTATHERA and PLUVICTO to the Veterans Integrated Service Network 10 (VISN 10) of the U.S. Department of Veterans Affairs (VA). The contract has a total ceiling value of $1,956,064.53 and an ultimate completion date of December 31, 2023. It was awarded on January 1, 2023 to Advanced Accelerator Applications USA Inc., a foreign-owned, for-profit manufacturer of radiopharmaceuticals and nuclear...
This federal contract award was made by the Veterans Integrated Service Network 10 (VISN 10), a division of the Department of Veterans Affairs (VA), to Advanced Accelerator Applications USA Inc., a foreign-owned, for-profit manufacturer of radiopharmaceuticals and nuclear medicine products. The $2,329,881.26 Firm Fixed Price contract is a Delivery Order issued under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) to procure the radiopharmaceuticals PLUVICTO and LUTATHERA....
This federal contract award was issued by the Veterans Integrated Service Network 4 (VISN 4), a division of the U.S. Department of Veterans Affairs (VA), to Advanced Accelerator Applications USA Inc., a foreign-owned, for-profit manufacturer of radiopharmaceuticals and nuclear medicine products. The $1,934,973.04 Firm Fixed Price delivery order contract will deliver LUTATHERA and PLUVICTO isotopes, which are used in cancer treatment and diagnostic imaging procedures, through December 31, 2025....
This federal contract award was issued by the Veterans Integrated Service Network 15 (VISN 15), a division of the U.S. Department of Veterans Affairs (VA), to Advanced Accelerator Applications USA Inc., a foreign-owned, for-profit manufacturer of radiopharmaceuticals and nuclear medicine products. The $1,493,266.26 Blanket Purchase Agreement (BPA) call contract is for the procurement of the radiopharmaceuticals PLUVICTO and LUTATHERA, which are used in cancer treatment and diagnostic imaging....
This is a $2,476,989.38 delivery order contract awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Advanced Accelerator Applications USA Inc., a foreign-owned, for-profit manufacturer of radiopharmaceutical products. The contract is for the delivery of radiopharmaceuticals, including PLUVICTO, LUTATHERA, and other nuclear medicine products, to support diagnostic imaging, cancer treatment, and other medical applications at VA medical facilities. The contract is...
This federal contract award is for the purchase of medications on an "as-needed" basis for 8 months, with a ceiling value of $731,041.08. The award was made to Advanced Accelerator Applications USA Inc., a foreign-owned, for-profit manufacturer of radiopharmaceutical and nuclear medicine products, under a GSA Pharmaceutical and Drugs Schedule contract. The contract is a Delivery Order with a Firm Fixed Price pricing type. The contract supports the procurement of Advanced Accelerator...
The Department of Veterans Affairs Veterans Health Administration has awarded a firm fixed price delivery order to Advanced Accelerator Applications USA Inc., a foreign-owned for-profit manufacturer of radiopharmaceuticals, to provide 3 doses of Lutetium Dotatate. The $112,221.42 contract was awarded on June 3, 2021, with a completion date of December 31, 2021. This order was placed through the Pharmaceuticals and Drugs (FSS-61-IB) Federal Supply Schedule. Advanced Accelerator Applications USA...
This federal contract award is for a Blanket Purchase Agreement (BPA) call with Advanced Accelerator Applications USA Inc., a foreign-owned, for-profit manufacturer of radiopharmaceuticals and nuclear medicine products. The contract is being administered by the Veterans Integrated Service Network 2, a civilian agency within the Department of Veterans Affairs (VA). The award is for the radiopharmaceutical product PLUVICTO (lutetium Lu 177 vipivotide tetraxetan), which is used for cancer...
This is a federal contract award to Advanced Accelerator Applications USA Inc., a foreign-owned, for-profit manufacturer of radiopharmaceuticals and nuclear medicine products. The contract is a Blanket Purchase Agreement (BPA) call under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB), with a ceiling value of $1,200,000.00. The contract is for the delivery of the radiopharmaceuticals PLUVICTO and LUTATHERA, which are used in cancer treatment and diagnostic imaging. The contract...
This federal contract award to Advanced Accelerator Applications USA Inc., a foreign-owned, for-profit manufacturer of radiopharmaceuticals, is for the supply of the radiopharmaceutical product PLUVICTO. The $1,721,672.68 Firm Fixed Price contract is a Blanket Purchase Agreement (BPA) Call under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) with the Department of Veterans Affairs (VA). The contract has an ultimate completion date of September 30, 2025 and does not have a...